Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Chastain

Showing results (31-40 of 111) with videos related to

Pageof 12
Sort By:
Pharmacy (Basel, Switzerland)|August 14, 2019
Antimicrobial Desensitization: A Review of Published ProtocolsDaniel B Chastain, Vanessa Johanna Hutzley, Jay Parekh, et al.
Pharmacotherapy|November 7, 2017
Strength in Amalgamation: Newer Combination Agents for HIV and Implications for PracticeChristopher McCoy, Melissa Badowski, Elizabeth Sherman, et al.
AIDS Care|August 24, 2023
ART-related medication errors in hospitalized people with HIV in the INSTI-era: analysis from 2 health systems in South Georgia, U.SDaniel B Chastain, Jessica Curtis, Emily Tang, et al.
Transplantation and Cellular Therapy|February 19, 2026
Incidence, Recurrence, Timing, and Economic Impact of Infections After CAR T-Cell Therapy: A Real-World Analysis from MarketScan DatabaseMohammed Zuber, Shaimaa Elshafie, Daniel B Chastain, et al.
Drug Design, Development and Therapy|March 16, 2023
Kimyrsa and Orbactiv - A Tale of Two FormulationsBrittany T Jackson, David B Cluck, Andrés F Henao-Martínez, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 26, 2018
Evaluating guideline adherence regarding empirical vancomycin use in patients with neutropenic feverDaniel B Chastain, Sarah Wheeler, Carlos Franco-Paredes, et al.
Annals of Clinical Microbiology and Antimicrobials|June 1, 2017
Effect of the 2014 Clinical and Laboratory Standards Institute urine-specific breakpoints on cefazolin susceptibility rates at a community teaching hospitalDaniel B Chastain, Ijang Ngando, Christopher M Bland, et al.
AIDS (London, England)|February 2, 2023
Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohortDaniel B Chastain, Gabriel Motoa, Yeimer Ortiz-Martínez, et al.
Medical Mycology|July 26, 2023
Invasive pulmonary aspergillosis real-world outcomes: Clinical features and risk factors associated with increased mortalityAndrés F Henao-Martínez, Michaele Francesco Corbisiero, Ixchel Salter, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2026
Precision dosing of systemic antifungals in adults: therapeutic drug monitoring, empiric dose optimization and barriers to implementationDaniel B Chastain, Daniel T Anderson, Joshua Eudy, et al.
Pageof 12

Showing results (31-40 of 111) with videos related to

Sort By:
Pageof 12
Pharmacy (Basel, Switzerland)|August 14, 2019
Antimicrobial Desensitization: A Review of Published ProtocolsDaniel B Chastain, Vanessa Johanna Hutzley, Jay Parekh, et al.
Pharmacotherapy|November 7, 2017
Strength in Amalgamation: Newer Combination Agents for HIV and Implications for PracticeChristopher McCoy, Melissa Badowski, Elizabeth Sherman, et al.
AIDS Care|August 24, 2023
ART-related medication errors in hospitalized people with HIV in the INSTI-era: analysis from 2 health systems in South Georgia, U.SDaniel B Chastain, Jessica Curtis, Emily Tang, et al.
Transplantation and Cellular Therapy|February 19, 2026
Incidence, Recurrence, Timing, and Economic Impact of Infections After CAR T-Cell Therapy: A Real-World Analysis from MarketScan DatabaseMohammed Zuber, Shaimaa Elshafie, Daniel B Chastain, et al.
Drug Design, Development and Therapy|March 16, 2023
Kimyrsa and Orbactiv - A Tale of Two FormulationsBrittany T Jackson, David B Cluck, Andrés F Henao-Martínez, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 26, 2018
Evaluating guideline adherence regarding empirical vancomycin use in patients with neutropenic feverDaniel B Chastain, Sarah Wheeler, Carlos Franco-Paredes, et al.
Annals of Clinical Microbiology and Antimicrobials|June 1, 2017
Effect of the 2014 Clinical and Laboratory Standards Institute urine-specific breakpoints on cefazolin susceptibility rates at a community teaching hospitalDaniel B Chastain, Ijang Ngando, Christopher M Bland, et al.
AIDS (London, England)|February 2, 2023
Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohortDaniel B Chastain, Gabriel Motoa, Yeimer Ortiz-Martínez, et al.
Medical Mycology|July 26, 2023
Invasive pulmonary aspergillosis real-world outcomes: Clinical features and risk factors associated with increased mortalityAndrés F Henao-Martínez, Michaele Francesco Corbisiero, Ixchel Salter, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2026
Precision dosing of systemic antifungals in adults: therapeutic drug monitoring, empiric dose optimization and barriers to implementationDaniel B Chastain, Daniel T Anderson, Joshua Eudy, et al.
Pageof 12